Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD...

por Ramos, Mafalda, Haughney, John, Henry, Nathaniel, Lindner, Leandro, Lamotte, Mark
Publicado 2016

Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China

por Salem, Ahmed, Zhong, Heng, Ramos, Mafalda, Lamotte, Mark, Hu, Hao
Publicado 2021

Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China

por Ramos, Mafalda, Men, Peng, Wang, Xu, Ustyugova, Anastasia, Lamotte, Mark
Publicado 2021

Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Ca...

por Ramos, Mafalda, Foos, Volker, Ustyugova, Anastasia, Hau, Nikco, Gandhi, Pranav, Lamotte, Mark
Publicado 2019

Cost-effectiveness of physical activity in the management of COPD patients in the UK

por Ramos, Mafalda, Lamotte, Mark, Gerlier, Laetitia, Svangren, Per, Miquel-Cases, Anna, Haughney, John
Publicado 2019

Long-Term Cost-Effectiveness Analyses of Empagliflozin Versus Oral Semaglutide, in Addition to Metformin, for the Treatment of Type 2 Diabetes in the UK

por Ramos, Mafalda, Cummings, Michael H., Ustyugova, Anastasia, Raza, Syed I., de Silva, Shamika U., Lamotte, Mark
Publicado 2020

Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy

por McCrimmon, Rory J., Lamotte, Mark, Ramos, Mafalda, Alsaleh, Abdul Jabbar Omar, Souhami, Elisabeth, Lew, Elisheva
Publicado 2021

The Cost-Effectiveness of Subcutaneous Semaglutide Versus Empagliflozin in Type 2 Diabetes Uncontrolled on Metformin Alone in Denmark

por Ehlers, Lars H., Lamotte, Mark, Ramos, Mafalda C., Sandgaard, Susanne, Holmgaard, Pia, Kristensen, Malene M., Ejskjaer, Niels
Publicado 2022

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States

por Biskupiak, Joseph E, Ramos, Mafalda, Levy, Carol J, Forlenza, Greg, Hopley, Colin, Boyd, Jennifer, Swift, Dan, Lamotte, Mark, Brixner, Diana I
Publicado 2023

Exploring Structural Uncertainty and Impact of Health State Utility Values on Lifetime Outcomes in Diabetes Economic Simulation Models: Findings from the Ninth Mount Hood Diabetes...

por Tew, Michelle, Willis, Michael, Asseburg, Christian, Bennett, Hayley, Brennan, Alan, Feenstra, Talitha, Gahn, James, Gray, Alastair, Heathcote, Laura, Herman, William H., Isaman, Deanna, Kuo, Shihchen, Lamotte, Mark, Leal, José, McEwan, Phil, Nilsson, Andreas, Palmer, Andrew J., Patel, Rishi, Pollard, Daniel, Ramos, Mafalda, Sailer, Fabian, Schramm, Wendelin, Shao, Hui, Shi, Lizheng, Si, Lei, Smolen, Harry J., Thomas, Chloe, Tran-Duy, An, Yang, Chunting, Ye, Wen, Yu, Xueting, Zhang, Ping, Clarke, Philip
Publicado 2021